Arthritis

The burden of hip osteoarthritis has increased globally in the past 30 years, with incidence and disability-adjusted life years rising “in nearly all countries,” according to data published in Arthritis Research & Therapy.

Sinusitis, acute respiratory tract burden and even pharyngitis — also known as the common cold — are potential risk factors for rheumatoid arthritis, according to data published in The Journal of Rheumatology.

The FDA has approved the seventh biosimilar to adalimumab, adalimumab-aqvh, for all eligible indications of the biologic product, the latest in an increasingly crowded biosimilar logjam set to release in 2023.

Patients developing rheumatoid arthritis can experience a 30% loss in work productivity a full year before the disease clinically manifests, according to data published in Rheumatology.

Physical activity, defined as recreational whole-body physiological energy expenditure, and time spent in physical activity are not associated with knee osteoarthritis outcomes, according to data published in Arthritis & Rheumatology.

Recent data found that dermatomyositis was more prevalent than had been thought. The retrospective, population-based cohort study that led to this conclusion was the top story in rheumatology last week.

A median of just 16.2% of adults with arthritis attended a self-management class in 2019, while that same year 69.3% received counseling for physical activity from their provider, according to CDC researchers.

Secukinumab is efficacious in children and adolescents with psoriatic arthritis and enthesitis-related arthritis, resulting in a significantly longer time to flare versus placebo, according to data presented at ACR Convergence 2021.

Abatacept is superior to placebo in improving subclinical inflammation in patients who are at high risk for rheumatoid arthritis, and in slowing arthritis progression, at 6 months, according to data presented at ACR Convergence 2021.

The FDA has approved a supplemental new drug application for ANI Pharmaceutical’s Cortrophin Gel to treat rheumatoid arthritis, multiple sclerosis and certain other autoimmune diseases, according to a company press release.